Management of the Complications of Radical Prostatectomy
Overview
Authors
Affiliations
Over the past several years, the morbidity associated with radical prostatectomy has improved due to advances in surgical technique, better understanding of male pelvic anatomy, and improved perioperative care. Despite these advances, patients are still at risk for several complications both intraoperatively and in the postoperative course. These risks include significant blood loss, rectal injury, ureteral injury, thromboembolic events, urinary incontinence, impotence, and a perioperative death rate of less than 1%. These risks should be reviewed and discussed before treating the patient with prostate cancer.
Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer.
Brown D, Lindmark F, Stattin P, Balter K, Adami H, Zheng S Clin Cancer Res. 2009; 15(21):6658-64.
PMID: 19843661 PMC: 3557964. DOI: 10.1158/1078-0432.CCR-08-3126.
Established prostate cancer susceptibility variants are not associated with disease outcome.
Wiklund F, Adami H, Zheng S, Stattin P, Isaacs W, Gronberg H Cancer Epidemiol Biomarkers Prev. 2009; 18(5):1659-62.
PMID: 19423541 PMC: 3353269. DOI: 10.1158/1055-9965.EPI-08-1148.
Management of complications of prostate cancer treatment.
Michaelson M, Cotter S, Gargollo P, Zietman A, Dahl D, Smith M CA Cancer J Clin. 2008; 58(4):196-213.
PMID: 18502900 PMC: 2900775. DOI: 10.3322/CA.2008.0002.